Article

Mmarketwatch.com on 2019-04-22 15:25

Trevi Therapeutics to offer 6.7 million shares in planned IPO priced at $14 to $16 each

Trevi Therapeutics set terms for its planned initial public offering on Monday, saying it plans to offer 4.7 million shares priced at $14 to $16 each to...

Needham

Related news

MBiotech Nurix Therapeutics to offer 11 million shares in planned IPO, priced at $17 to $18 each marketwatch.com
Needham
MHookipa Pharma to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MBiotech Arvinas to offer 6.7 million shares in IPO priced at $14 to $16 each marketwatch.com
MBiotech Cibus to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MTurning Point Therapeutics to sell 7.4 million shares in IPO, priced at $16 to $18 each marketwatch.com
Turning Point
MAxonics to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MProgenity to offer 6.7 million shares in planned IPO priced at $14 to $16 each marketwatch.com
MAprea Therapeutics to offer 5 million shares in its IPO, priced at $14 to $16 each marketwatch.com
MPandion Therapeutics upsizes planned IPO, to offer 7 million shares priced at $16 to $18 each marketwatch.com
MRapt Therapeutics to offer 3 million shares in planned IPO priced at $12 to $14 each marketwatch.com
MPandion Therapeutics to offer 5.5 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MLyra Therapeutics to offer 3.5 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MADC Therapeutics to offer 7.36 million shares in IPO, priced at $16 to $18 each marketwatch.com
Switzerland
MDyne Therapeutics to offer 10.3 million shares in IPO priced at $16 to $18 each marketwatch.com
MADC Therapeutics to offer 8.1 million shares in planned IPO, priced at $23 to $26 each marketwatch.com
MBeam Therapeutics to offer 6.25 million shares in planned IPO priced at $15 to $17 each marketwatch.com
MFreeline Therapeutics to offer 7.35 million ADS in IPO, priced at $16 to $18 each marketwatch.com
MGalera Therapeutics to offer 5 million shares in IPO priced at $14 to $16 each marketwatch.com
MBlack Diamond Therapeutics to offer 8.9 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MPandion Therapeutics' upsized IPO priced at the top of the expected range marketwatch.com